|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 09766879.2 (espacenet) (Federated) (European Patent Register), 20090619 | Patent/reg. no. and date | DK/EP 2297207, 20181003 | Publication date | 20110323 | Priority no. and date | US 73882, 20080619, US 73882 P, 20080619 | EP pub. no. and date |
EP 2297207 20110323 | Effective date | | Applicant/owner | Prothix BV, Warmonderweg 23
2334 AB Leiden, NL | Applicant ref. no. | P81803293DK00E | Inventor | Hack, Erik, Paulus Emtinckweg 40
NL-1111 BV Diemen, NL | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 39/395 (2006.01) , C07K 14/745 (2006.01) , C07K 16/36 (2006.01) | Title | ANVENDELSE AF ANTI-FAKTOR XI-ANTISTOFFER TIL FOREBYGGELSE ELLER BEHANDLING AF THROMBEDANNELSE | Int. application no. | NL2009050361 | Int. publication no. | WO2009154461 | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |